Carl R. Illig

719 citations

21 papers · 499 indexed · h-index 13

Co-authors: Roger Bone Richard Söll John Spurlino Renée L. DesJarlais Kenneth J. Wilson Christopher J. Molloy Bruce E. Tomczuk Mark R. Player
Topics: Peptidase Inhibition and Analysis (6 papers)Chemical Synthesis and Analysis (5 papers)Click Chemistry and Applications (3 papers)
Cited by: Sensory Systems Organic Chemistry Toxicology
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry Tetrahedron Letters
Partner nations: United States Belgium

In The Last Decade

Carl R. Illig

21 papers receiving 470 citations

Peers

Countries citing papers authored by Carl R. Illig

Since Specialization

Citations

This map shows the geographic impact of Carl R. Illig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl R. Illig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl R. Illig more than expected).

Fields of papers citing papers by Carl R. Illig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl R. Illig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl R. Illig. The network helps show where Carl R. Illig may publish in the future.

Co-authorship network of co-authors of Carl R. Illig

This figure shows the co-authorship network connecting the top 25 collaborators of Carl R. Illig. A scholar is included among the top collaborators of Carl R. Illig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl R. Illig. Carl R. Illig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Sanath K. Meegalla,Hui Huang,Carl R. Illig,Daniel J. Parks,(unknown),(unknown),Kenneth J. Wilson,Sharmila Patel,Wing S. Cheung,Tianbao Lu,Thomas Kirchner,(unknown),John G. Geisler,Raymond J. Patch,Alan C. Gibbs,(unknown),Margery A. Connelly,Mark R. Player	11
2	Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Carl R. Illig,Carl L. Manthey,Sanath K. Meegalla,Mark J. Wall,(unknown),Kenneth J. Wilson,Renée L. DesJarlais,Shelley K. Ballentine,Carsten J. Schubert,Carl Crysler,Yanmin Chen,Christopher J. Molloy,Margery A. Chaikin,Robert R. Donatelli,Edward J. Yurkow,Zhou Zhao,Mark R. Player,Bruce E. Tomczuk	3
3	Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Kenneth J. Wilson,Carl R. Illig,(unknown),Mark J. Wall,Shelley K. Ballentine,Renée L. DesJarlais,Yanmin Chen,Carsten J. Schubert,Robert R. Donatelli,Ioanna P. Petrounia,Carl Crysler,Christopher J. Molloy,Margery A. Chaikin,Carl L. Manthey,Mark R. Player,Bruce E. Tomczuk,Sanath K. Meegalla	9
4	Design and Optimization of Benzimidazole-Containing Transient Receptor Potential Melastatin 8 (TRPM8) Antagonists 2010 ·Journal of Medicinal Chemistry ·Daniel J. Parks,William H. Parsons,Raymond W. Colburn,Sanath K. Meegalla,Shelley K. Ballentine,Carl R. Illig,Na Qin,Yi Liu,Tasha L. Hutchinson,Mary Lou Lubin,Dennis J. Stone,Judith F. Baker,Craig R. Schneider,Jianya Ma,Bruce P. Damiano,Christopher M. Flores,Mark R. Player	59
5	Structure-based optimization of a potent class of arylamide FMS inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Sanath K. Meegalla,Mark J. Wall,(unknown),Kenneth J. Wilson,Shelley K. Ballentine,Renée L. DesJarlais,Carsten J. Schubert,Carl Crysler,Yanmin Chen,Christopher J. Molloy,Margery A. Chaikin,Carl L. Manthey,Mark R. Player,Bruce E. Tomczuk,Carl R. Illig	26
6	Discovery of novel FMS kinase inhibitors as anti-inflammatory agents 2008 ·Bioorganic & Medicinal Chemistry Letters ·Carl R. Illig,(unknown),Mark J. Wall,Kenneth J. Wilson,Shelley K. Ballentine,Matthias Rudolph,Renée L. DesJarlais,Yanmin Chen,Carsten J. Schubert,Ioanna P. Petrounia,Carl Crysler,Christopher J. Molloy,Margery A. Chaikin,Carl L. Manthey,Mark R. Player,Bruce E. Tomczuk,Sanath K. Meegalla	40
7	Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Mark J. Wall,(unknown),Sanath K. Meegalla,Shelley K. Ballentine,Kenneth J. Wilson,Renée L. DesJarlais,Carsten J. Schubert,Margery A. Chaikin,Carl Crysler,Ioanna P. Petrounia,Robert R. Donatelli,Edward J. Yurkow,(unknown),(unknown),Mark R. Player,Raymond J. Patch,Carl L. Manthey,Christopher J. Molloy,Bruce E. Tomczuk,Carl R. Illig	45
8	Cyano-Substituted 2-Carboxyimidazoles:Synthesis of 4-Cyano-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-imidazole-2-carboxylate Potassium Salt 2008 ·Synthesis ·Mark J. Wall,Carsten J. Schubert,Carl R. Illig	2
9	A novel series of potent and selective small molecule inhibitors of the complement component C1s 2004 ·Bioorganic & Medicinal Chemistry Letters ·Nalin L. Subasinghe,(unknown),Carl R. Illig,Matthias Rudolph,Scott I. Klein,Ehab M. Khalil,Richard Söll,Roger Bone,John Spurlino,Renée L. DesJarlais,Carl Crysler,Maxwell D. Cummings,Philip E. Morris,John Michael Kilpatrick,Y. Sudhakara Babu	18
10	Design and Synthesis of 4,5-Disubstituted-thiophene-2-amidines as Potent Urokinase Inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·Matthias Rudolph,Carl R. Illig,Nalin L. Subasinghe,Kenneth J. Wilson,(unknown),(unknown),David Green,Christopher J. Molloy,Richard Söll,Frank Lewandowski,Marie Zhang,Roger Bone,John Spurlino,Ingrid C. Deckman,Carl L. Manthey,Celia Sharp,Diane Maguire,Bruce Grasberger,Renée L. DesJarlais,Zhou Zhao	23
11	Synthesis of thiophene-2-carboxamidines containing 2-amino-thiazoles and their biological evaluation as urokinase inhibitors 2001 ·Bioorganic & Medicinal Chemistry Letters ·Kenneth J. Wilson,Carl R. Illig,Nalin L. Subasinghe,(unknown),Matthias Rudolph,Richard Söll,Christopher J. Molloy,Roger Bone,David Green,Troy D. Randall,Marie Zhang,Frank Lewandowski,(unknown),Celia Sharp,Diane Maguire,Bruce Grasberger,Renée L. DesJarlais,John Spurlino	88
12	Amidinohydrazones as guanidine bioisosteres: application to a new class of potent, selective and orally bioavailable, non-amide-based small-molecule thrombin inhibitors 2000 ·Bioorganic & Medicinal Chemistry Letters ·Richard Söll,(unknown),Bruce E. Tomczuk,Carl R. Illig,(unknown),Stephen Eisennagel,Roger Bone,(unknown),John Spurlino,F. Raymond Salemme	33
13	Structure–activity and crystallographic analysis of a new class of non-amide-based thrombin inhibitor 2000 ·Bioorganic & Medicinal Chemistry Letters ·Tianbao Lu,Richard Söll,Carl R. Illig,Roger Bone,(unknown),John Spurlino,F. Raymond Salemme,(unknown)	11
14	1,3,5-Trialkyl-2,4,6-triiodobenzenes: Novel X-ray Contrast Agents for Gastrointestinal Imaging 2000 ·Journal of Medicinal Chemistry ·Kimberly G. Estep,Kurt A. Josef,Edward R. Bacon,Carl R. Illig,John L. Toner,Dinesh Kumar Mishra,William F. Blazak,Dennis M. Miller,David K. Johnson,(unknown),(unknown),Susan Wilson	14
15	In vitro evaluation and crystallographic analysis of a new class of selective, non-amide-based thrombin inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·Tianbao Lu,Bruce E. Tomczuk,Carl R. Illig,Roger Bone,(unknown),John Spurlino,F. Raymond Salemme,Richard Söll	20
16	Structural Analysis of Thrombin Complexed with Potent Inhibitors Incorporating a Phenyl Group as a Peptide Mimetic and Aminopyridines as Guanidine Substitutes 1998 ·Journal of Medicinal Chemistry ·Roger Bone,Tianbao Lu,Carl R. Illig,Richard Söll,John Spurlino	21
17	Win 70197: a novel liver-targeted magnetic resonance imaging contrast agent 1995 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Ping Guo,Carl R. Illig,Kenneth E. Kellar,(unknown),Jian Shen,(unknown),David L. Ladd,(unknown),John L. Toner	5
18	Stereoselective synthesis of (.+-.)-cyanocycline 1986 ·Journal of the American Chemical Society ·David A. Evans,Carl R. Illig,(unknown)	32
19	Nitrone cycloadditions. regiochemistry. 1979 ·Tetrahedron Letters ·Shaikh A. Ali,(unknown),Carl R. Illig,(unknown),Joseph J. Tufariello	9
20	Natural Gas Supplies for Tomorrow 1954 ·Law and Contemporary Problems ·(unknown),Carl R. Illig	2

About Carl R. Illig

Carl R. Illig is a scholar working on General Energy, Organic Chemistry and Genetics, having authored 21 papers that have together received 499 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Chemical Synthesis and Analysis (5 papers) and Click Chemistry and Applications (3 papers). The work is most often cited by research in Sensory Systems (46 citations), Organic Chemistry (262 citations) and Toxicology (19 citations). Carl R. Illig has collaborated with scholars based in United States and Belgium. Frequent co-authors include Roger Bone, Richard Söll, John Spurlino, Renée L. DesJarlais, Kenneth J. Wilson, Christopher J. Molloy, Bruce E. Tomczuk, Mark R. Player, Sanath K. Meegalla and Shelley K. Ballentine. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact